40 Manning Road
386 articles with Bruker Corporation
Bruker Launches the S2 POLAR™ High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry
he S2 POLAR offers the same excellent analytical precision for quality control in the petrochemical industry
Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
Acquisition expands Bruker's Microbiology & Diagnostics business with profitable Molecular Diagnostics portfolio and substantial innovation pipeline
Bruker Announces Breakthrough Proteomics and Lipidomics Workflow Advances for the timsTOF™ Pro at HUPO 2018
First Large-Scale Use of Peptide CCS Values to Enhance Search Specificity
Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH
Bruker's MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections
Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock.
Investment of £20 Million for Eight UK Universities Includes Two 1 GHz Systems
Bruker Corporation announced financial results for its second quarter and six months ended June 30, 2018.
Bruker Announces Acquisition of Lactotronic to Expand Technology and Product Portfolio for Food Analysis in the Dairy Industry
Bruker announced today that it has acquired the business of Lactotronic B.V.
Bruker Launches New Sierra™ SPR-32 High-Performance Surface Plasmon Resonance System at SLAS Europe 2018
Sierra SPR-32 Combines Highest SPR Throughput and Outstanding Sensitivity
Bruker Introduces ParaVision® 360 Preclinical Imaging Software and AVANCE® NEO Systems with Advanced Multi-Receive Architecture for MRI
At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360.
Bruker will support Intabio's development of their microchip-based solution for real-time, intact biopharmaceutical analysis
Bruker announced the launch of the SKYSCAN™ 2214
Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018
Improved IR Biotyper™ system for fast, routine and cost-effective strain typing for hospital infection control and earlier detection of outbreaks
Mr. Herman brings more than 30 years of financial, accounting and operations leadership experience to Bruker's CFO position.
Bruker Corporation announced it will present at the following conferences
Bruker Acquires Sierra Sensors to Expand Real-Time, Label-Free Detection Portfolio for Pharma and Biopharma Drug Discovery
Bruker announced that it has acquired Sierra Sensors GmbH, based in Hamburg, Germany.
Bruker Introduces scimaX™ MRMS for Novel Phenomics Workflows, and Further Enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets.
Bruker Corporation (NASDAQ: BRKR) today announced payment of a quarterly cash dividend in the amount of $0.04 per share on the Company's common stock.
Bruker Corporation announced it will participate in the 43rd Annual Deutsche Bank Health Care Conference in Boston.
InNEOvations™ at ENC 2018 Enable Deeper Insights into the Structure, Dynamics and Function of Structured, Unstructured and Membrane Proteins, and of Advanced Materials